Finding ways to simplify user interfaces to improve accessibility, refine algorithms and explore broader applications of this ...

EpiWatch — a Johns Hopkins Medicine spinout — has received FDA 510(k) premarket clearance for its seizure detection platform ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

This virtual support group is open to adults, parents and caregivers. It provides a place to share experiences, provide encouragement and offer support through the epilepsy journey. The group meets on ...

A grieving mother is attempting to raise £750,000 to improve epilepsy care through technology ... asked to fill in a manual seizure diary. "The medical team were having to make quite speedy ...

Epilepsy refers to a group of neurological disorders of varying aetiology, characterized by recurrent brain dysfunction that result from sudden excessive and disordered neuronal discharge. These ...

Join us in-person or virtually to raise awareness and funds to END EPILEPSY. With each step taken and dollar raised, we're closer to reaching our goal: a world free from epilepsy and free from fear of ...

A new phospholipid complex significantly enhances the solubility and absorption of cannabidiol (CBD), a non-psychoactive cannabis compound used for treating epilepsy and multiple sclerosis.

The research team believes that this innovation could be applied beyond CBD, providing a blueprint for enhancing the absorption of other poorly water-soluble drugs. With the global CBD market ...